Improving Adherence to Oral Cancer Agents and Self Care of Symptoms Using an IVR
Trial Purpose and Description
This longitudinal randomized trial tests and compares two strategies for improving patient adherence to their oral medication prescriptions.
1. Cancer patients assigned to the intervention will have greater adherence to their prescribed regimen a) at weeks 4 (immediate effect), and be) at weeks 8, and 12 weeks (sustained effect).
2. When compared with patients receiving weekly assessments only, patients receiving weekly assessments plus daily adherence reminders and printed symptom management strategies for 4 weeks will report: lower symptom severity during weeks 2-4 that will be sustained at weeks 5-8, and at 12 weeks.
- 21 Years and older
Patient Inclusion Criteria:
- 21 years of age or older
- diagnosed with solid tumor cancer
- new, first prescription of select oral chemotherapy agent (non-hormonal)
- cognitively intact (as determined by the study recruiter)
- able to speak, read, and understand English
- able and willing to receive phone calls
- for the IVR study: ECOG Performance 0-2 or Karnofsky 50 or higher
- for the text study: having a personal cell phone, and able and willing to receive and send text messages.
- National Cancer Institute
- Last Updated:
- Study HIC#: